Power estimation
A marked reduction of symptoms in 15% of the patients is considered clinically
relevant
A study of 150 patients with a 1:1 randomisation will have a power of approximately
80% to detect a difference in response rate of 10% versus 25% in a study without
crossover
The crossover design will further improve statistical power